Immuneering (IMRX) Other Operating Expenses (2022 - 2026)

Immuneering (IMRX) posted quarterly Other Operating Expenses of $7317.0 for Q1 2026, little changed year-over-year from $7317.0 in Q1 2025, and little changed quarter-over-quarter from $7317.0 in Q4 2025.

Immuneering (IMRX) Other Operating Expenses (2022 - 2026) Analysis & Trends

Immuneering's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $7317.0 for Q1 2026.

  • In Q1 2026, Other Operating Expenses changed 0.0% year-over-year to $7317.0; the TTM figure through Mar 2026 stood at $29268.0 (changed 0.0% YoY), while the FY2025 annual figure was $29267.0, changed 0.0% from the prior year.
  • Other Operating Expenses for Q1 2026 stood at $7317.0, roughly flat from $7317.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $8103.0 in Q1 2022, with the low at $7316.0 in Q4 2022.
  • The 5-year median for Other Operating Expenses is $7317.0 (2022), against an average of $7363.2.
  • Peak annual rise in Other Operating Expenses reached 0.01% in 2023, while the deepest fall reached 9.7% in 2023.
  • Immuneering's Other Operating Expenses stood at $7316.0 in 2022, then rose by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
  • Business Quant data shows IMRX's Other Operating Expenses at $7317.0 in Q1 2026, $7317.0 in Q4 2025, and $7317.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Immuneering 327.37 Mn 327.37 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 7,317.00
Mar 31, 2026 7,317.00
Dec 31, 2025 7,317.00
Sep 30, 2025 7,317.00
Jun 30, 2025 7,317.00
Mar 31, 2025 7,317.00
Dec 31, 2024 7,317.00
Sep 30, 2024 7,317.00
Jun 30, 2024 7,317.00
Mar 31, 2024 7,317.00
Dec 31, 2023 7,317.00
Sep 30, 2023 7,317.00
Jun 30, 2023 7,317.00
Mar 31, 2023 7,317.00
Dec 31, 2022 7,316.00
Sep 30, 2022 7,317.00
Jun 30, 2022 7,317.00
Mar 31, 2022 8,103.00